PureTech Health logo

PureTech Health

North America, Massachusetts, United States, Boston

Description

PureTech Health is a bio pharma company and pushes the boundaries of medicine and changing and converging healthcare ecosystem.

Investor Profile

PureTech Health has made 19 investments, with 1 in the past 12 months and 11% as lead.

Stage Focus

  • Series B (32%)
  • Series A (26%)
  • Private Equity (11%)
  • Series Unknown (11%)
  • Series E (11%)
  • Series D (5%)
  • Series C (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Diabetes
  • Medical Device
  • Neuroscience
  • Business Development
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PureTech Health frequently co-invest with?

Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Invesco
North America, Georgia, United States, Atlanta
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 3
PF
North America, Illinois, United States, Chicago
Co-Investments: 2
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does PureTech Health often collaborate with?

SP
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by PureTech Health?

Seaport Therapeutics

Boston, Massachusetts, United States

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 21, 2024
Amount Raised: $225,000,000
Seaport Therapeutics

Boston, Massachusetts, United States

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

BiotechnologyPharmaceutical
Series AApr 9, 2024
Amount Raised: $100,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series EApr 25, 2023
Amount Raised: $106,500,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series DJul 21, 2021
Amount Raised: $68,000,000
Vor Biopharma

Cambridge, Massachusetts, United States

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

BiotechnologyHealth CareOncologyPharmaceutical
Series BJul 7, 2020
Amount Raised: $110,000,000
Karuna Therapeutics

Boston, Massachusetts, United States

Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.

BiopharmaHealth CareTherapeutics
Series BMar 18, 2019
Amount Raised: $68,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series CDec 24, 2018
Amount Raised: $45,394,519
Karuna Therapeutics

Boston, Massachusetts, United States

Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.

BiopharmaHealth CareTherapeutics
Series AAug 2, 2018
Amount Raised: $42,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Private EquityJun 6, 2016
Amount Raised: $50,000,000
Akili Interactive Labs

Boston, Massachusetts, United States

Akili Interactive Labs Provides Healthcare Treatments.

BiotechnologyHealth CareMedicalNeuroscienceService IndustryTherapeutics
Series BJan 22, 2016
Amount Raised: $30,500,000